The BRICHOS domain is a molecular chaperone known for its ability to prevent amyloid and amorphous protein aggregation, playing a critical role in protecting cells from protein misfolding. ZoBio has an active collaboration with the Karolinska Institutet, where we are exploring the Bri2 BRICHOS…
15th Swiss Course on Medicinal Chemistry in Leysin
In person As in previous years, ZoBio was proud to be a sponsor of the 15th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting…
BioJapan 2024
In person For the first time, ZoBio was excited to participate in BioJapan 2024, an event held in conjunction with Regenerative Medicine Japan and healthTECH Japan. As Asia’s largest partnering event, it offers a comprehensive platform through its three main programs: exhibition, seminars, and partnering. Jan Schultz attended One-on-One meetings to share insights about our…
Discovery on Target
In person Our team was excited to participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from…